Oncolytics Biotech Inc.
corporate_fare Company Profile
Oncolytics Biotech Inc. (NASDAQ:ONCY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 42 items for ONCY at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Oncolytics Biotech Q1 Net Loss Widens to $9.24M, Cash Runway Under 12 Months
- Q1 Report Confirms Going Concern, Reveals $2.3M Dilutive ATM Sales
- Oncolytics Biotech Reports 3-4x Improvement in Colorectal Cancer Response Durability, Pursues Accelerated FDA Approval
- Oncolytics' Pelareorep Shows 3-4x Longer Response in Colorectal Cancer, Eyes Accelerated FDA Approval
- Oncolytics Biotech Aligns with FDA on Pivotal Anal Cancer Study Design
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$28.76M
Diluted EPS
-$0.30
Op. Cash Flow
-$20.11M
Free Cash Flow
-$20.12M
Operating Income
-$28.73M
Cash & Equivalents
$5.2M
Debt / Equity
0.00×
Shares Outstanding
108.02M sh
Source: 10-K · filed 2026-03-30 · accession 0001129928-26-000020
show_chartPrice Chart
Loading chart...
feed ONCY - Filings & News (Page 2)
ONCY
May 14, 2026, 4:41 PM EDT
Price at Filing:
$0.8615
Real-time Price:
$0.3699
Change:
-$0.4916 (-57%)
Market Cap:
$47.663M
ONCY
May 14, 2026, 4:30 PM EDT
Price at Filing:
$0.862
Real-time Price:
$0.3699
Change:
-$0.4921 (-57%)
Market Cap:
$47.663M
ONCY
May 04, 2026, 9:03 AM EDT
Price at Filing:
$0.9506
Real-time Price:
$0.3699
Change:
-$0.5807 (-61%)
Market Cap:
$47.663M
ONCY
May 04, 2026, 9:00 AM EDT
Price at Filing:
$0.8894
Real-time Price:
$0.3699
Change:
-$0.5195 (-58%)
Market Cap:
$47.663M
ONCY
Apr 27, 2026, 8:16 AM EDT
Price at Filing:
$1.14
Real-time Price:
$0.3699
Change:
-$0.7701 (-68%)
Market Cap:
$47.663M
ONCY
Apr 06, 2026, 4:12 PM EDT
Price at Filing:
$0.950
Real-time Price:
$0.3699
Change:
-$0.5801 (-61%)
Market Cap:
$47.663M
ONCY
Apr 06, 2026, 4:11 PM EDT
Price at Filing:
$0.950
Real-time Price:
$0.3699
Change:
-$0.5801 (-61%)
Market Cap:
$47.663M
ONCY
Apr 06, 2026, 9:24 AM EDT
Price at Filing:
$0.969
Real-time Price:
$0.3699
Change:
-$0.5991 (-62%)
Market Cap:
$47.663M
ONCY
Apr 01, 2026, 9:07 AM EDT
Price at Filing:
$0.8051
Real-time Price:
$0.3699
Change:
-$0.4352 (-54%)
Market Cap:
$47.663M
ONCY
Mar 31, 2026, 9:50 PM EDT
Price at Filing:
$0.8051
Real-time Price:
$0.3699
Change:
-$0.4352 (-54%)
Market Cap:
$47.663M
ONCY
Mar 30, 2026, 5:35 PM EDT
Price at Filing:
$0.8051
Real-time Price:
$0.3699
Change:
-$0.4352 (-54%)
Market Cap:
$47.663M
ONCY
Mar 30, 2026, 5:29 PM EDT
Price at Filing:
$0.810
Real-time Price:
$0.3699
Change:
-$0.4401 (-54%)
Market Cap:
$47.663M
ONCY
Mar 20, 2026, 4:43 PM EDT
Price at Filing:
$0.960
Real-time Price:
$0.3699
Change:
-$0.5901 (-61%)
Market Cap:
$47.663M
ONCY
Mar 19, 2026, 9:05 AM EDT
Price at Filing:
$0.9541
Real-time Price:
$0.3699
Change:
-$0.5842 (-61%)
Market Cap:
$47.663M
ONCY
Mar 02, 2026, 10:44 AM EST
Price at Filing:
$1.05
Real-time Price:
$0.3699
Change:
-$0.6751 (-65%)
Market Cap:
$47.663M
ONCY
Feb 24, 2026, 9:10 AM EST
Price at Filing:
$1.05
Real-time Price:
$0.3699
Change:
-$0.6801 (-65%)
Market Cap:
$47.663M
ONCY
Feb 04, 2026, 12:05 PM EST
Price at Filing:
$0.95235
Real-time Price:
$0.3699
Change:
-$0.58245 (-61%)
Market Cap:
$47.663M
ONCY
Jan 15, 2026, 4:21 PM EST
Price at Filing:
$1.03
Real-time Price:
$0.3699
Change:
-$0.6601 (-64%)
Market Cap:
$47.663M
ONCY
Jan 14, 2026, 6:10 PM EST
Price at Filing:
$1.00
Real-time Price:
$0.3699
Change:
-$0.6308 (-63%)
Market Cap:
$47.663M
ONCY
Jan 12, 2026, 4:05 PM EST
Oncolytics Biotech Reports Strong Pelareorep Data in Anal Cancer, Plans Accelerated Approval Pathway
Price at Filing:
$0.9916
Real-time Price:
$0.3699
Change:
-$0.6217 (-63%)
Market Cap:
$47.663M